Curriculum

Menopause Reimagined: Integrating Emerging Science and Non-Hormonal Therapies

Vasomotor symptoms (VMS) affect millions of midlife women, yet many go undertreated. Gain a deeper understanding of the neuroendocrine mechanisms driving menopausal symptoms, the latest nonhormonal treatment options, and the long-term cardiometabolic risks of delayed intervention—empowering more confident, individualized conversations with patients.

Loading... Begin

CME Information

1.50 AMA PRA Category 1 Credits™, 1.50 ABIM MOC or 1.50 AANP, 1.25 AANP Pharm

Release Date: 5/14/2026

Available for credit until 5/14/2027

Topics

Faculty

Learning Objectives

  • Describe the neuroendocrine mechanisms underlying vasomotor symptoms (VMS) and other menopausal manifestations, including the role of the kisspeptin/neurokinin B/dynorphin (KNDy) neuron system
  • Evaluate the efficacy, safety, and mechanisms of action of new and emerging non-hormonal therapies for VMS 
  • Discuss the long-term health implications of untreated menopausal symptoms and the role of early intervention in reducing cardiometabolic risk 
  • Employ shared decision-making with midlife women regarding individualized treatment options for menopause-related symptoms"

Courses

1.50 CME/CE CREDITS

2 Courses

Faculty

Amy Clouse, MD, FAAFP

Clinical Associate Professor of Family and Community Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania

Read More
lisa larkin
Lisa Larkin, MD, FACP, NCMP, IF

Founder and CEO, Ms.Medicine

Read More

Supported By

Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

Education Partner

Pri-Med Institute